Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
saxagliptin (onglyza) (1 trial)
anti-cd33 car-nk cells (1 trial)
bcma car-nk 92 cells (1 trial)
cll1-cd33 ccar t cells (1 trial)
cyclophosphamide (cytoxan) (3 trials)
fludarabine (fludara) (3 trials)
Diabetic Foot (Phase 4)
Foot Ulcer (Phase 4)
Ulcer (Phase 4)
Trials (4 total)
Trial APIs (6 total)